| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |